ElectricProtect Corporation Filed Patent Infringement Lawsuit to Protect Electrical Safety Innovations
Multiple Brands Voluntarily Cease Procurement of Alleged Infringing Products
Purcellville appoints Anthony Sabio as interim town manager
A last-minute agenda item was added to Wednesday’s Purcellville Town Council meeting to enter a closed session to appoint a new interim town manager.
Mastercard and Thunes Bring Stablecoin Payouts to the Mainstream
Collaboration to enable payouts to stablecoin wallets, giving banks, payment providers, and end-users greater choice and flexibility
Entrepreneur Universe Bright Group Reports Third Quarter 2025 Financial Results
XI’AN, China, Nov. 12, 2025 /PRNewswire/ — Entrepreneur Universe Bright Group (“EUBG” or the “Company”), a Nevada corporation, today announced its unaudited financial results for the quarter ended September 30, 2025.
Orvana Argentina Commences Geophysical Survey at Taguas Project, Argentina
TORONTO, Nov. 12, 2025 /PRNewswire/ – Orvana Minerals Corp. (TSX: ORV) (the “Company” or “Orvana”) announces that its Argentine subsidiary, Orvana Argentina S.A., has commenced a geophysical survey at its Taguas Project, located in the high Andes of San Juan…
Leesburg yard waste collection ends for 2025
Yard waste collection for the 2025 season will conclude on Monday, Nov. 24 in Leesburg. Yard waste will not be collected during the months of December, January, February or March.
Phillips & Associates Exposes How Power Shields Workplace Harassment
Ahead of the 2026 National Plaintiffs’ Summit on Sexual Harassment and Employment Discrimination, William K. Phillips—founding partner of Phillips & Associates—exposes how corporate power shields harassers, empowering employees to seek justice in New York and beyond.
Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development
– Using Ascletis’ proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist, demonstrated a comparable pharmacokinetic (PK) profile to ASC36 and ASC35 dosed alone…
r4 Technologies Donates Smart Food AI Program to Help States Feed SNAP Beneficiaries
Smart Food Program reframes hunger as a logistics problem, rather than a supply issue.
Wildermuth Fund Mutual Fund Investors Have Opportunity to Lead Wildermuth Fund Securities Fraud Lawsuit
NEW YORK, Nov. 12, 2025 /PRNewswire/ —